Product ID |
Product Name |
CAS# |
Purity |
Y3307245 |
PNZ5 |
1629277-36-6 |
99% |
Y3293499 |
HJB97 |
2093391-24-1 |
98% |
Y1302997 |
Fmoc-(S)-2-amino-5-(3,5-dimethylphenyl)pentanoic acid |
2104031-58-3 |
95% |
Y3291166 |
BMVC |
627810-06-4 |
99% |
Y3104207 |
Deltatsine |
92631-66-8 |
98.0% |
Y1259070 |
Fluzoparib |
1358715-18-0 |
99% |
Y3312820 |
Guajadial C |
1529775-02-7 |
95% |
Y3317204 |
2-Chloro-4-fluoro-L-phenylalanine |
1213560-44-1 |
97% |
Y1232686 |
BRD-6929 |
849234-64-6 |
99% |
Y3258125 |
N-(2-Bromobenzyl)methanesulfonamide |
889131-25-3 |
95% |
Y1232697 |
Taltirelin acetate |
1549593-23-8 |
98% |
Y3305834 |
5-Acetyltaxachitriene A |
187988-48-3 |
98.0% |
Y3104196 |
2-(4-Formylphenoxy)-butanoic acid |
480994-55-6 |
97% |
Y3260521 |
Beraprost sodium |
496807-11-5 |
99% |
Y3313474 |
20-Deacetyltaxuspine X |
284672-76-0 |
95% |
Y3317339 |
13-Deacetyltaxachitriene A |
239800-99-8 |
97.0% |
Y3104319 |
Spiratisanin B |
1902173-19-6 |
97.5% |
Y3104320 |
Spiratisanin C |
1902173-22-1 |
96.0% |
Y1263313 |
ASP6432 |
1282549-08-9 |
95% |
Y3106275 |
Decinnamoyltaxagifine |
130394-69-3 |
97.5% |
Y3106297 |
Cinchonain IIb |
85022-68-0 |
95% |
Y1263286 |
(Rac)-IDO1-IN-5 |
2166616-74-4 |
99% |
Y1263436 |
Dihydromunduletone |
674786-20-0 |
99% |
Y3316011 |
Physapruin A |
155178-03-3 |
96.5% |
Y3285731 |
N-Acetyl lysyltyrosylcysteine amide |
1287585-40-3 |
99% |
Y1342823 |
Pentagamavunon-1 |
27060-70-4 |
99% |
Y3317106 |
9-Deacetyltaxinine E |
284672-78-2 |
97.0% |
Y3316157 |
13-O-Cinnamoylbaccatin III |
220932-65-0 |
98.0% |
Y3286802 |
ASP-4058 |
952565-91-2 |
97% |
Y1232853 |
Thalidomide-O-C8-Boc |
2225148-52-5 |
95% |
Y1232698 |
IL-15-IN-1 |
1831830-20-6 |
99% |
Y3255190 |
3,5-Dichloro-N-cyclopropylaniline |
1369359-26-1 |
95% |
Y3313622 |
Elubrixin |
688763-64-6 |
98% |
Y1263317 |
EST64454 |
1950569-11-5 |
99% |
Y3318711 |
2-Deacetoxydecinnamoyltaxinine J |
87193-98-4 |
98.0% |
Y1342491 |
Melflufen hydrochloride |
380449-54-7 |
99% |
Y3316248 |
20)abeotaxa-4(20),11-dien-10-one'>2alpha,7beta,13alpha-Triacetoxy-5alpha-cinnamoyloxy-9beta-hydroxy-2(3->20)abeotaxa-4(20),11-dien-10-one |
322471-42-1 |
95% |
Y3288755 |
IL-17A antagonist 3 |
2230780-65-9 |
98% |
Y1263437 |
Omidenepag |
1187451-41-7 |
99% |
Y3297325 |
Velagliflozin |
946525-65-1 |
99% |
Y3267992 |
SP4206 |
515846-21-6 |
98% |
Y3263478 |
3,5-Difluoro-N-cyclopropylaniline |
1506097-42-2 |
95% |
Y3306805 |
JAK2/FLT3-IN-1 |
2387765-27-5 |
99.79% |
Y1263287 |
BAY-1316957 |
1613264-40-6 |
98% |
Y3314657 |
Hydrangenoside A dimethyl acetal |
952485-00-6 |
95% |
Y1232854 |
1,1'-[Methylenebis(2,6-diethyl-4,1-phenylene)]bis[3-(2-nitrophenyl)urea] |
2414546-93-1 |
98% |
Y3317295 |
Ylangenyl acetate |
90039-63-7 |
95% |
Y3294245 |
PIM1-IN-1 |
1417630-95-5 |
99% |
Y3104361 |
Traxillaside |
149415-62-3 |
97.5% |
Y3318152 |
Curcumaromin C |
1810034-40-2 |
95% |
Y3260078 |
KRAS G12C inhibitor 15 |
2349393-21-9 |
99% |
Y3313641 |
Nardoaristolone B |
1422517-82-5 |
98% |
Y3289788 |
Kaempferol 3-O-rhamninoside |
83170-31-4 |
95% |
Y3104370 |
Curcumaromin A |
1810034-38-8 |
95% |
Y3243950 |
AMG2850 |
1470018-52-0 |
99% |
Y3104255 |
(R)-Methyl 2,3-diaminopropanoate 2HCl |
686259-72-3 |
97% |
Y1334926 |
O-(2-Methoxyphenyl)-L-serine |
1509916-93-1 |
97% |
Y3104281 |
VBIT-4 |
2086257-77-2 |
98+% |
Y3104256 |
N-[2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl]-b-alanine |
2225940-46-3 |
95% |
Y3310771 |
DHODH-IN-13 |
1364791-86-5 |
99% |
Y3235006 |
Tungstate (WO42-), dihydrogen, (T-4)- |
7783-03-1 |
99.9% |
Y1291429 |
2H-1-Benzopyran-3-carboxylic acid, 7-hydroxy-2-oxo- |
779-27-1 |
98% |
K07335 |
Pyrimidine, 2-(1-piperazinyl)-, monohydrochloride |
78069-54-2 |
97% |
Y1247004 |
1-(3-METHYLPYRIDIN-2-YL)ETHANOL |
780804-99-1 |
95% |
Y1336444 |
4-(N-Boc-n-methylamino)-benzaldehyde |
780821-17-2 |
95% |
Y3289138 |
Potassium 4-chlorobenzenesulfonate |
78135-07-6 |
98% |
D752744 |
Benzoicacid, 3-(4-methylphenoxy)-, methyl ester |
78303-09-0 |
95+% |
Y1315567 |
Phenol, 2-fluoro-4-pentyl- |
78322-87-9 |
98% |
D766621 |
3-Isoxazolemethanol, 5-methyl-, methanesulfonate (ester) |
783325-24-6 |
95% |
Y3312584 |
Pyrimidine, 2-chloro-5-iodo-4-(trifluoromethyl)- |
785777-99-3 |
97% |
Y3231667 |
4-[3-(2-chloroacetyl)-2,5-dimethyl-1H-pyrrol-1-yl]benzene-1-sulfonamide |
785792-42-9 |
90% |
D772515 |
4-(2-(1,3-Dioxoisoindolin-2-Yl)Ethyl)Phenyl Pivalate |
785849-99-2 |
95% |
Y1247005 |
(2S)-2-{[(tert-butoxy)carbonyl]amino}-3-(2,5,7-tri-tert-butyl-1H-indol-3-yl)propanoicacid |
78654-82-7 |
98% (HPLC) |
D772516 |
1,2,3,4-Tetrahydropyrazino[2,1-A]Isoindol-6(10Bh)-One |
79016-59-4 |
95% |
Y3267630 |
Benzonitrile, 2-[2-[4-[2-(3-cyanophenyl)ethenyl]phenyl]ethenyl]- |
79026-03-2 |
98%(HPLC) |
Y3267652 |
1-[4-methoxy-3-(pyrrolidin-1-ylmethyl)phenyl]ethan-1-one |
790263-38-6 |
94% |
Y3266356 |
(1-cyclopropylethyl)(2,2,2-trifluoroethyl)amine |
790263-40-0 |
90% |
Y3315670 |
FD-838 |
110341-78-1 |
95% |
Y3316307 |
Isozedoarondiol |
108887-68-9 |
98.0% |
Y3316710 |
1,7-Dihydroxyacridone |
112649-95-3 |
95% |
Y3290396 |
DMU2105 |
1031063-36-1 |
98% |
Y3313662 |
Alterlactone |
1030376-89-6 |
97.5% |
Y3308663 |
DMU2139 |
104890-70-2 |
98% |
Y3318439 |
Deoxyflindissone |
107176-31-8 |
93.0% |
Y3289056 |
Isoeleutherin |
1078723-14-4 |
98% |
Y3314199 |
4-Chloropinselin |
104022-83-5 |
95% |
Y3309240 |
yuanamide |
102421-42-1 |
95% |
Y3315855 |
Runanine |
100485-12-9 |
98.0% |
Y3309896 |
Astraisoflavan-7-O-ß-D-glucoside |
1011711-05-9 |
98% |
Y3102145 |
Chlorahololide C |
1007859-25-7 |
98.0% |
Y3315640 |
kuwanon T |
100187-66-4 |
98% |
Y1262387 |
1,3-Benzenedicarboxylic acid, 5,5',5''-(1,3,5-triazine-2,4,6-triyltriimino)tris- |
776242-98-9 |
97% |
Y3307834 |
DecurosideV |
96648-59-8 |
98% |
Y3101969 |
2-Acetamino-3'-methylbiphenyl |
869631-33-4 |
95% |
Y3101972 |
Tri-(4-hydroxy-TEMPO)phosphite |
2122-49-8 |
95% |
Y3316903 |
DisperseOrange30 |
12223-23-3 |
AR |
Y1259064 |
2-((N-(2-Methoxyphenyl)-4-methylphenyl)sulfonamido)-N-(4-methoxypyridin-3-yl)acetamide |
1890208-58-8 |
97% |
Y3318656 |
erythro-Guaiacylglycerol beta-sinapyl ether |
877875-96-2 |
98.0% |
Y3313762 |
Ketohakonanol |
18004-20-1 |
99.0% |
Y3311146 |
Bonducellin |
83162-84-9 |
98.0% |